| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/12/2003 | CA2469093A1 A novel herbal chemical composition for the treatment of cancer |
| 06/12/2003 | CA2469085A1 Pharmaceutical combinations of adenosine a-2a and beta-2-adrenergic receptor agonists |
| 06/12/2003 | CA2468996A1 Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer |
| 06/12/2003 | CA2468967A1 N-aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
| 06/12/2003 | CA2468944A1 Migration of hematopoietic stem cells and progenitor cells to the liver |
| 06/12/2003 | CA2468907A1 Effectors of innate immunity |
| 06/12/2003 | CA2468839A1 Methods of treating cancer using an fpt inhibitor and anti neoplastic agents |
| 06/12/2003 | CA2468701A1 T-bet compositions and methods of use thereof |
| 06/12/2003 | CA2468698A1 Methods and compositions for modulating the immune system and uses thereof |
| 06/12/2003 | CA2468676A1 Combination of a selective pde4 inhibitor and an adrenergic beta-2 receptor agonist |
| 06/12/2003 | CA2468558A1 "compressed annular tablet with molded triturate tablet for oral and intraoral" |
| 06/12/2003 | CA2468463A1 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 06/12/2003 | CA2468407A1 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 06/12/2003 | CA2468067A1 Metabotropic glutamate receptor-5 modulators |
| 06/12/2003 | CA2467333A1 Methods for monitoring amyotrophic lateral sclerosis |
| 06/12/2003 | CA2467073A1 Peptides and method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases |
| 06/12/2003 | CA2466762A1 Raf-mek-erk pathway inhibitors to treat cancer |
| 06/12/2003 | CA2466757A1 Method for treating ocular hypertension |
| 06/12/2003 | CA2466649A1 Use of norepinephrine reuptake inhibitors for the treatment of tic disorders |
| 06/11/2003 | EP1318407A1 Use of aldose-1-epimerase (mutarotase) for the diagnosis and therapy of infections and sepsis |
| 06/11/2003 | EP1317927A1 Minor histocompatibility antigen HA-1: target antigen for immunotherapy of tumors |
| 06/11/2003 | EP1317926A1 Xenon inhalant for pain treatment |
| 06/11/2003 | EP1317924A1 Kit for reducing aching caused by pde-v inhibitors |
| 06/11/2003 | EP1317922A1 Antipyretic preparation containing xylitol |
| 06/11/2003 | EP1317915A1 Hair nourishments and method of screening the same |
| 06/11/2003 | EP1317669A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 06/11/2003 | EP1317554A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 06/11/2003 | EP1317541A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/11/2003 | EP1317537A2 G-csf analog compositions and methods |
| 06/11/2003 | EP1317531A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 06/11/2003 | EP1317487A2 Caveolin peptides and their use as therapeutics |
| 06/11/2003 | EP1317486A1 Interferon-alpha induced gene |
| 06/11/2003 | EP1317485A2 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 06/11/2003 | EP1317483A2 Variants of allergenic proteins of the group 2 of dermatophagoides |
| 06/11/2003 | EP1317453A1 Isoxazoles and their use as inhibitors of erk |
| 06/11/2003 | EP1317452A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/11/2003 | EP1317450A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/11/2003 | EP1317449A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/11/2003 | EP1317448A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/11/2003 | EP1317447A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/11/2003 | EP1317444A1 Pyrazole compounds useful as protein kinase inhibitors |
| 06/11/2003 | EP1317419A1 Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |
| 06/11/2003 | EP1317412A1 Compounds and compositions for delivering active agents |
| 06/11/2003 | EP1317309A2 Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant |
| 06/11/2003 | EP1317288A2 Method and composition for treating tumors by selective induction of apoptosis |
| 06/11/2003 | EP1317287A2 Polymeric conjugates of antitumor agents |
| 06/11/2003 | EP1317286A2 Contraception process and administration form for the same |
| 06/11/2003 | EP1317285A1 Methods for treating demyelinating diseases |
| 06/11/2003 | EP1317283A2 Tweak receptor agonists as anti-angiogenic agents |
| 06/11/2003 | EP1317278A2 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 06/11/2003 | EP1317270A1 Exemestane for the treatment of oestrogen-dependent cancers |
| 06/11/2003 | EP1317265A2 Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency |
| 06/11/2003 | EP1317259A2 Prevention of acute sinusitis and sinus attack |
| 06/11/2003 | EP1317258A2 Use of agents capable of reducing uric acid levels for the treatment of cardiovascular disease |
| 06/11/2003 | EP1317256A2 Pharmaceutical composition having modified carrier |
| 06/11/2003 | EP1317252A2 Pharmaceutical composition having specific water activity |
| 06/11/2003 | EP1317238A1 Compositions containing a vitamin c component and pigment |
| 06/11/2003 | EP1317226A1 Treatment of human herpesviruses using hyperthermia |
| 06/11/2003 | EP1228077B1 Ruthenium (ii) complexes with high antitumoral and antimetastatic activities |
| 06/11/2003 | EP1156828B1 Combination therapy for lymphoproliferative diseases |
| 06/11/2003 | EP1133307B1 Use of a composition comprising soy protein, dietary fibres and a phytoestrogen compound in the prevention and/or treatment of pulmonary diseases |
| 06/11/2003 | EP1039891A4 Treatment of scar tissue using lipoic acid |
| 06/11/2003 | EP1024810A4 Method for optimizing retinal and optic nerve health |
| 06/11/2003 | EP0910382B1 Squalamine in combination with other anti-cancer agents for treating tumors |
| 06/11/2003 | EP0821586B1 A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers |
| 06/11/2003 | CN1423748A Solution and crystal structures of MMP-13 active sidte and uses thereof |
| 06/11/2003 | CN1423660A Antibodies |
| 06/11/2003 | CN1423658A Modulation of human sodium channels in dorsal root ganglia |
| 06/11/2003 | CN1423656A Lipopeptides as antibacterial agents |
| 06/11/2003 | CN1423566A 体重增加抑制剂 Weight gain inhibitor |
| 06/11/2003 | CN1423565A 精子因子oscillogenin Sperm factor oscillogenin |
| 06/11/2003 | CN1423564A APLIDINE treatment of cancers |
| 06/11/2003 | CN1423563A Pancreatic stem cells and their use in transplantation |
| 06/11/2003 | CN1423559A Controlled-release compositions containing opioid agonist and antagonist |
| 06/11/2003 | CN1423556A Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication |
| 06/11/2003 | CN1423555A 掩蔽味道的涂料组合物 Taste-masking coating composition |
| 06/11/2003 | CN1423528A Nutritional modules |
| 06/11/2003 | CN1422620A Aerosol for treating poisoning by nitrogen oxide and its use and preparation method |
| 06/11/2003 | CN1111068C Strong anti-oxidative composite capsule of grape seed extract OPC and its production method |
| 06/10/2003 | US6576793 β2-adrenergic receptor agonists |
| 06/10/2003 | US6576759 Antiproliferative agents; anticancer agents; rheumatic disorders; administering nucleotide |
| 06/10/2003 | US6576671 Left ventricular dysfunction; 5,6-dihydroxy- or 5,6-diiso-butyroloxy-2-methylaminotetralin |
| 06/10/2003 | US6576670 Administering 1-(2-fluorophenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one-ortho-2 -(dimethylaminoethyl)-oxime or its hemi-fumerate salt |
| 06/10/2003 | US6576669 Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes |
| 06/10/2003 | US6576666 First fatty acid compound that is a linoleic or linolenic compound and a second fatty acid that is a docosahexaenoic acid compound, an omega-3 or an omega-2 fatty acid or derivative |
| 06/10/2003 | US6576653 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 06/10/2003 | US6576650 No central nervous system side effects |
| 06/10/2003 | US6576638 Use of substance P antagonists in the treatment of the adenocarcinomas |
| 06/10/2003 | US6576630 Compounds and compositions as protease inhibitors |
| 06/10/2003 | US6576624 Administering domperidone or pimozide jointly with miltefo-sine; reducing side effect of decrease in body weight |
| 06/10/2003 | US6576464 Methods for providing differentiated stem cells |
| 06/10/2003 | US6576439 Contacting protein of given sequence with a test compound and detecting modulating activity; drug screening; can use for treatment of inflammatory conditions |
| 06/10/2003 | US6576437 Stimulus-inducible protein kinase complex and methods of use therefor |
| 06/10/2003 | US6576434 Transport protein of given amino acid sequence; exposing cells that express the protein to compound; measuring ion transport; use in treatment of interleukin mediated atopic allergy, asthma and cystic fibrosis |
| 06/10/2003 | US6576431 Treatment for myocardial infarction; enhancing clot lysis |
| 06/10/2003 | US6576267 Composition and method for treating the effects of diseases and maladies |
| 06/10/2003 | US6576258 Anhydrous granulation of active substances and dried pharmaceutically acceptable auxiliary substances for the preparation of pellet cores or granules, drug delivery |
| 06/10/2003 | US6576256 Treatment of patients at elevated cardiovascular risk with a combination of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
| 06/10/2003 | US6576252 Composition providing calming, stress hormone regulating and immune stimulation effect, which comprises component including combination of linoleic and linolenic acids in specified ratio, and component taken from flavonoid group |
| 06/10/2003 | US6576248 Pigmented vitamin C composition |